105 related articles for article (PubMed ID: 17175038)
1. Parallel inactivation of Y2 receptor and G-proteins in CHO cells by pertussis toxin.
Parker SL; Parker MS; Sah R; Sallee FR; Balasubramaniam A
Regul Pept; 2007 Mar; 139(1-3):128-35. PubMed ID: 17175038
[TBL] [Abstract][Full Text] [Related]
2. Pertussis toxin induces parallel loss of neuropeptide Y Y1 receptor dimers and Gi alpha subunit function in CHO cells.
Parker SL; Parker MS; Sah R; Balasubramaniam A; Sallee FR
Eur J Pharmacol; 2008 Jan; 579(1-3):13-25. PubMed ID: 17967449
[TBL] [Abstract][Full Text] [Related]
3. Supersensitivity to mu-opioid receptor-mediated inhibition of the adenylyl cyclase pathway involves pertussis toxin-resistant Galpha protein subunits.
Mostany R; Díaz A; Valdizán EM; Rodríguez-Muñoz M; Garzón J; Hurlé MA
Neuropharmacology; 2008 May; 54(6):989-97. PubMed ID: 18384820
[TBL] [Abstract][Full Text] [Related]
4. Oligomerization of neuropeptide Y (NPY) Y2 receptors in CHO cells depends on functional pertussis toxin-sensitive G-proteins.
Parker SL; Parker MS; Sallee FR; Balasubramaniam A
Regul Pept; 2007 Dec; 144(1-3):72-81. PubMed ID: 17651824
[TBL] [Abstract][Full Text] [Related]
5. Neuropeptide Y (NPY) Y2 receptors of rabbit kidney cortex are largely dimeric.
Estes AM; Wong YY; Parker MS; Sallee FR; Balasubramaniam A; Parker SL
Regul Pept; 2008 Oct; 150(1-3):88-94. PubMed ID: 18585408
[TBL] [Abstract][Full Text] [Related]
6. Neuropeptide Y as a partial agonist of the Y1 receptor.
Sah R; Balasubramaniam A; Parker MS; Sallee F; Parker SL
Eur J Pharmacol; 2005 Nov; 525(1-3):60-8. PubMed ID: 16293244
[TBL] [Abstract][Full Text] [Related]
7. Maintenance of Y receptor dimers in epithelial cells depends on interaction with G-protein heterotrimers.
Estes AM; McAllen K; Parker MS; Sah R; Sweatman T; Park EA; Balasubramaniam A; Sallee FR; Walker MW; Parker SL
Amino Acids; 2011 Feb; 40(2):371-80. PubMed ID: 20577889
[TBL] [Abstract][Full Text] [Related]
8. Internalization of cloned pancreatic polypeptide receptors is accelerated by all types of Y4 agonists.
Parker MS; Sah R; Sheriff S; Balasubramaniam A; Parker SL
Regul Pept; 2005 Dec; 132(1-3):91-101. PubMed ID: 16213038
[TBL] [Abstract][Full Text] [Related]
9. Self-regulation of agonist activity at the Y receptors.
Parker SL; Parker MS; Sah R; Balasubramaniam A; Sallee FR
Peptides; 2007 Feb; 28(2):203-13. PubMed ID: 17194507
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of neuropeptide Y-mediated calcium responses in human SMS-KAN neuroblastoma cells endogenously expressing Y2 receptors by co-expression of chimeric G proteins.
Dautzenberg FM
Biochem Pharmacol; 2005 May; 69(10):1493-9. PubMed ID: 15857613
[TBL] [Abstract][Full Text] [Related]
11. Role of G-protein beta gamma subunits in the augmentation of P2Y2 (P2U)receptor-stimulated responses by neuropeptide Y Y1 Gi/o-coupled receptors.
Selbie LA; King NV; Dickenson JM; Hill SJ
Biochem J; 1997 Nov; 328 ( Pt 1)(Pt 1):153-8. PubMed ID: 9359846
[TBL] [Abstract][Full Text] [Related]
12. Role of the C terminus in neuropeptide Y Y1 receptor desensitization and internalization.
Holliday ND; Lam CW; Tough IR; Cox HM
Mol Pharmacol; 2005 Mar; 67(3):655-64. PubMed ID: 15576634
[TBL] [Abstract][Full Text] [Related]
13. Increased brain neuropeptide Y1 and Y2 receptor binding in NPY knock out mice does not result in increased receptor function.
Gehlert DR; Shaw JL
Peptides; 2007 Feb; 28(2):241-9. PubMed ID: 17208335
[TBL] [Abstract][Full Text] [Related]
14. Fluorescence- and luminescence-based methods for the determination of affinity and activity of neuropeptide Y2 receptor ligands.
Ziemek R; Brennauer A; Schneider E; Cabrele C; Beck-Sickinger AG; Bernhardt G; Buschauer A
Eur J Pharmacol; 2006 Dec; 551(1-3):10-8. PubMed ID: 17027743
[TBL] [Abstract][Full Text] [Related]
15. Short- and long-term regulation of adenylyl cyclase activity by delta-opioid receptor are mediated by Galphai2 in neuroblastoma N2A cells.
Zhang L; Tetrault J; Wang W; Loh HH; Law PY
Mol Pharmacol; 2006 Jun; 69(6):1810-9. PubMed ID: 16525132
[TBL] [Abstract][Full Text] [Related]
16. Muscarinic M2 receptors directly activate Gq/11 and Gs G-proteins.
Michal P; El-Fakahany EE; Dolezal V
J Pharmacol Exp Ther; 2007 Feb; 320(2):607-14. PubMed ID: 17065363
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization and appetite suppressive properties of BMS-193885, a novel and selective neuropeptide Y(1) receptor antagonist.
Antal-Zimanyi I; Bruce MA; Leboulluec KL; Iben LG; Mattson GK; McGovern RT; Hogan JB; Leahy CL; Flowers SC; Stanley JA; Ortiz AA; Poindexter GS
Eur J Pharmacol; 2008 Aug; 590(1-3):224-32. PubMed ID: 18573246
[TBL] [Abstract][Full Text] [Related]
18. Unaltered neuropeptide Y (NPY)-stimulated [35S]GTPgammaS binding suggests a net increase in NPY signalling after repeated electroconvulsive seizures in mice.
Christensen DZ; Olesen MV; Kristiansen H; Mikkelsen JD; Woldbye DP
J Neurosci Res; 2006 Nov; 84(6):1282-91. PubMed ID: 16941487
[TBL] [Abstract][Full Text] [Related]
19. G-protein coupled activation of potassium channels by endogenous neuropeptides in snail neurons.
Kiss T
Eur J Neurosci; 2005 Apr; 21(8):2177-85. PubMed ID: 15869514
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide Y receptor-mediated sensitization of ATP-stimulated inositol phosphate formation.
Drakulich DA; Walls AM; Toews ML; Hexum TD
J Pharmacol Exp Ther; 2003 Nov; 307(2):559-65. PubMed ID: 12970392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
